1. HBW Insight
  2. >>Ingredients & Safety
  3. >>Cannabis/CBD

US CBD Supplement Market Anxious For Lawful Use Proposal, And FDA Offers Cannabis Drug Research Guidance

 
• By Malcolm Spicer

Adding more cannabis-containing drugs to the three already approved in the US relies on research, but hundreds of supplements and other FDA-regulated non-drug products containing CBDs already are available under enforcement discretion by the agency.

ApplesOranges

US guidance on clinical research for developing drugs containing cannabis is needed as studies already are underway, but consumer health industry stakeholders might consider reminding the Food and Drug Administration that sales of hemp-derived cannabidiol products, all unlawful, continue soaring.

A proposed regulatory pathway to use CBDs in non-drug products, particularly in dietary supplements, food and personal care products, is needed as soon as the FDA can provide one, stakeholders tell HBW Insight

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cannabis/CBD

More from Ingredients & Safety